The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose intensity of neoadjuvant FOLFIRINOX (FFX) in borderline and locally advanced pancreatic cancer (LAPC): A comparison to the adjuvant benchmark.
 
Janet E. Murphy
No Relationships to Disclose
 
Leilana Ly
No Relationships to Disclose
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; MPM Capital; Oncorus
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Other Relationship - TCR2 Therapeutics
 
Jeffrey W. Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Beow Y Yeap
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
Aparna Raj Parikh
Employment - Genentech
 
Ryan David Nipp
No Relationships to Disclose
 
Eunice Lee Kwak
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen
 
Jill N. Allen
No Relationships to Disclose
 
Ryan Bruce Corcoran
Consulting or Advisory Role - Amgen; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Jason Edward Faris
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Exelixis; Millennium; Roche/Genentech
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Sanofi
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Lipika Goyal
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Thomas F. DeLaney
Honoraria - Oakstone Publishing; UpToDate; Wolters Kluwer
 
Cristina Ferrone
No Relationships to Disclose
 
Carlos Fernandez-del Castillo
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Abbvie; Bayer; Celgene; Genentech/Roche; Lilly; Millennium